General News
Meropi Kyriacou Honored as TNH Educator of the Year
NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.
COLOMBO, Sri Lanka — Sri Lanka is administering Pfizer shots to people who were left waiting after receiving their first AstraZeneca doses earlier this year.
Mixing two vaccines is still being studied for its effectiveness, but Sri Lanka health officials approved it due to a severe AstraZeneca shortage.
Sri Lanka received 26,000 doses of Pfizer on Monday as the first batch of 5 million shots to be received this year. It started rolling them out Wednesday to residents 55 and older in the capital Colombo.
About 384,000 people were fully vaccinated before Sri Lanka ran out of AstraZeneca doses with 540,000 people only partially vaccinated.
Channa Jayasumana, the state minister overseeing pharmaceuticals, said getting Pfizer as the 2nd dose was optional and a consignment of AstraZeneca vaccine was expected this month.
Sri Lanka also has used Sinopharm and the Russian Sputnik V to vaccinate people against COVID-19.
Sri Lanka has seen a sharp increase of coronavirus infections and deaths since April. It has recorded 266,499 cases with 3,268 fatalities overall.
NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.
MELBOURNE, Australia (AP) — More than 100 long-finned pilot whales that beached on the western Australian coast Thursday have returned to sea, while 29 died on the shore, officials said.
On Monday, April 22, 2024, history was being written in a Manhattan courtroom.
PARIS - With heavy security set for the 2024 Paris Olympic Games during a time of terrorism, France has asked to use a Greek air defense system as well although talks are said to have been going on for months.
PARIS (AP) — Paris has a new king of the crusty baguette.
WASHINGTON (AP) — A tiny Philip Morris product called Zyn has been making big headlines, sparking debate about whether new nicotine-based alternatives intended for adults may be catching on with underage teens and adolescents.